APLM CIK: 1944885

Apollomics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
99.4
FY22:
55.8
FY23:
39.9
FY24:
10.3
FY25:
6.05
(positive)
Change from FY21 to FY25
millions USD
FY21:
24.1
FY22:
20.7
FY23:
15.5
FY24:
2.83
FY25:
0.66
Total assets
Change from FY21 to FY25
millions USD
FY21:
123
FY22:
76.5
FY23:
55.4
FY24:
13.1
FY25:
6.71

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
13.6
FY22:
12.4
FY23:
13.6
FY24:
7.40
FY25:
6.33
(negative)
Change from FY21 to FY25
millions USD
FY21:
323
FY22:
436
FY23:
0.60
FY24:
0.84
FY25:
3.58
(positive)
Change from FY21 to FY25
millions USD
FY21:
−213
FY22:
−448
FY23:
41.2
FY24:
4.86
FY25:
−3.19
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
123
FY22:
–
FY23:
55.4
FY24:
13.1
FY25:
6.71

All amounts in millions USD Data sources:SEC EDGARTwelve Data